Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Traclet

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Pulmonology|December 9, 2025
Risk of hospitalisation and mortality among patients with interstitial lung disease and COVID-19: A French multicentre prospective cohortRémi Diesler, Laure Gallay, Yurdagül Uzunhan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 29, 2022
Targeting IL-5/5R for the treatment of idiopathic chronic eosinophilic pneumoniaQuentin Delcros, Camille Taillé, Alexandre Vallée, et al.
The European Respiratory Journal|May 26, 2022
An emerging phenotype of pulmonary arterial hypertension patients carrying <i>SOX17</i> variantsDavid Montani, Benoit Lechartier, Barbara Girerd, et al.
Chest|September 26, 2020
Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin CMarie-Caroline Certain, Marie-Camille Chaumais, Xavier Jaïs, et al.
ERJ Open Research|December 3, 2024
Pulmonary fibrosis in patients with autoimmune pulmonary alveolar proteinosis: a retrospective nationwide cohort studyYoann Guirriec, David Luque-Paz, Gontran Bernard, et al.
ERJ Open Research|January 21, 2026
Adult male patients with <i>DKC1</i> mutations present early-onset pulmonary fibrosis and severe prognosisOphélie Evrard, Quentin Philippot, Caroline Kannengiesser, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 6, 2020
Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung DiseaseLouis Chauvelot, Delphine Gamondes, Julien Berthiller, et al.
Frontiers in Medicine|August 23, 2021
Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal?Lucile Sesé, Hilario Nunes, Vincent Cottin, et al.
The European Respiratory Journal|December 8, 2018
Regulator of telomere length 1 (<i>RTEL1</i>) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypesRaphael Borie, Diane Bouvry, Vincent Cottin, et al.
Respiratory Medicine|May 9, 2021
Low income and outcome in idiopathic pulmonary fibrosis: An association to uncoverLucile Sesé, Julien Caliez, Isabella Annesi-Maesano, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Pulmonology|December 9, 2025
Risk of hospitalisation and mortality among patients with interstitial lung disease and COVID-19: A French multicentre prospective cohortRémi Diesler, Laure Gallay, Yurdagül Uzunhan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 29, 2022
Targeting IL-5/5R for the treatment of idiopathic chronic eosinophilic pneumoniaQuentin Delcros, Camille Taillé, Alexandre Vallée, et al.
The European Respiratory Journal|May 26, 2022
An emerging phenotype of pulmonary arterial hypertension patients carrying <i>SOX17</i> variantsDavid Montani, Benoit Lechartier, Barbara Girerd, et al.
Chest|September 26, 2020
Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin CMarie-Caroline Certain, Marie-Camille Chaumais, Xavier Jaïs, et al.
ERJ Open Research|December 3, 2024
Pulmonary fibrosis in patients with autoimmune pulmonary alveolar proteinosis: a retrospective nationwide cohort studyYoann Guirriec, David Luque-Paz, Gontran Bernard, et al.
ERJ Open Research|January 21, 2026
Adult male patients with <i>DKC1</i> mutations present early-onset pulmonary fibrosis and severe prognosisOphélie Evrard, Quentin Philippot, Caroline Kannengiesser, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 6, 2020
Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung DiseaseLouis Chauvelot, Delphine Gamondes, Julien Berthiller, et al.
Frontiers in Medicine|August 23, 2021
Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal?Lucile Sesé, Hilario Nunes, Vincent Cottin, et al.
The European Respiratory Journal|December 8, 2018
Regulator of telomere length 1 (<i>RTEL1</i>) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypesRaphael Borie, Diane Bouvry, Vincent Cottin, et al.
Respiratory Medicine|May 9, 2021
Low income and outcome in idiopathic pulmonary fibrosis: An association to uncoverLucile Sesé, Julien Caliez, Isabella Annesi-Maesano, et al.
Pageof 7